Andrew Carnell

Title: Andrew Carnell: Innovator in Biocatalytic Processes

Introduction

Andrew Carnell is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of biocatalysis, particularly in the development of processes for the formation of valuable chemical compounds. With a total of two patents to his name, Carnell's work showcases his innovative approach to chemical engineering.

Latest Patents

Carnell's latest patents include groundbreaking processes for the formation of furandicarboxylic acid (FDCA) via a multistep biocatalytic oxidation reaction of 5-hydroxymethylfurfural (HMF). This invention focuses on the use of specific enzymes, such as xanthine oxidoreductase and galactose oxidase variant M, to facilitate the conversion of HMF into FDCA and its derivatives. Additionally, he has developed a process for the N-demethylation or the N- and O-demethylation of a thebaine derivative, utilizing filamentous fungi as biocatalysts.

Career Highlights

Throughout his career, Andrew Carnell has worked with prominent companies, including Biome Bioplastics Limited and Reckitt Benckiser Healthcare (UK) Limited. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in bioplastics and healthcare products.

Collaborations

Carnell has collaborated with notable professionals in his field, including Paul William Law and Paul Robert Mines. These partnerships have further enriched his research and development efforts, leading to impactful innovations.

Conclusion

Andrew Carnell's contributions to biocatalytic processes and his innovative patents highlight his role as a significant figure in the field of chemical engineering. His work continues to influence advancements in sustainable chemistry and bioplastics.